Who is sponsoring NCT04571905?

NCT04571905 is sponsored by Thomas Krebs.

What drugs are being tested in NCT04571905?

Interventions in NCT04571905: Osteosynthesis with resorbable Material.

What condition does NCT04571905 study?

NCT04571905 studies Magnesium-based, Bioresrobable Implants, Pediatric Elbow Fractures, Osteosynthesis, Childhood, Magnezix, Elbow Fracture.

Is NCT04571905 still recruiting?

NCT04571905 is currently completed. Last updated 6 September 2023.

Last reviewed 2023-09-06 · How we verify

NCT04571905

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

MagnezixKids Study

Completed NA Last updated 6 September 2023

What this trial tests

NA trial testing Osteosynthesis with resorbable Material in Magnesium-based in 17 participants. Completed in 12 July 2023.

Timeline

1 August 2020

Primary endpoint
12 July 2023

12 July 2023

Quick facts

Lead sponsor	Thomas Krebs
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	17
Start date	1 August 2020
Primary completion	12 July 2023
Estimated completion	12 July 2023
Sites	1 location across Switzerland

Drugs / interventions tested

Osteosynthesis with resorbable Material

Conditions studied

Magnesium-based — all drugs for Magnesium-based →
Bioresrobable Implants — all drugs for Bioresrobable Implants →
Pediatric Elbow Fractures — all drugs for Pediatric Elbow Fractures →
Osteosynthesis — all drugs for Osteosynthesis →

Sponsor

Thomas Krebs

Who can join

Adults 3 to 15, any sex, with Magnesium-based or Bioresrobable Implants. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overall objective of the study is to describe the outcomes of osteosyn-thesis with magnesium based screws in children with a primary or second-ary (within 7 days from trauma) dislocated fracture of the Epicondyles ul-naris or Condylus radialis, and to compare them with outcomes of conven-tional osteosynthesis using steel screws. If our results suggest non-inferiority of osteosynthesis with magnesium-based screws, the procedure could be tested formally in a subsequent full-size study.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Making Hardware Removal Unnecessary by Using Resorbable Implants for Osteosynthesis in Children.
Heye P, Matissek C, Seidl C, Varga M, et al · · 2022 · cited 14× · PMID 35455515 · DOI 10.3390/children9040471

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04571905 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Thomas Krebs
Last refreshed: 6 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04571905.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing